开发和完善一个矩阵能力框架,与相关的可信任的专业活动,以支持科威特的初始药房教育
Pierre Moreau1, Mohammad Qaddoumi1, Dalal Al-Taweel1
1College of Pharmacy, Health Sciences Center, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait.
Pharmacy (Basel, Switzerland)
|September 22, 2023
概括
科威特本科药学教育的新能力框架是使用独特的矩阵结构来开发的. 该框架满足当地人口的需求,并通过定义基本能力和专业活动来增强药房实践.
科学领域:
- 药房教育 教育 药房教育
- 基于能力的教育 基于能力的教育
- 医疗保健劳动力发展工作人员
背景情况:
- 能力框架对于发展基于能力的教育至关重要.
- 具体的国家框架对于解决当地医疗保健需求至关重要.
- 这项研究的重点是制定一个框架,为科威特的本科药学教育.
研究的目的:
- 描述一个独特的矩阵结构能力框架的发展过程,用于科威特的本科药学教育.
- 确保框架与当地居民对药房服务的需求保持一致.
- 建立一个课程修订和实施的基础.
主要方法:
- 与关键利益相关者进行了需求评估.
- 确定了全球教育成果.
- 进行了定性数据的主题分析,以确定能力领域和可信任的专业活动 (EPA).
主要成果:
- 确定了五个人口需求,导致17个建议的EPA.
- 确定了11个能力领域.
- 开发了一个最初的3x8矩阵框架,后来改进以消除冗余并创建一个全球行为能力配置文件.
结论:
- 开发的矩阵能力框架和EPAs为科威特的药剂师培训提供了基础.
- 这一框架将有助于准备药剂师满足当地人口的需求,并扩大他们的实践范围.
- 它支持该国药房教育和实践的进步.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
28
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
28
Drug Administration and Therapy Phases: Overview
504
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
504
Model Approaches for Pharmacokinetic Data: Compartment Models
122
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
122
Three-Compartment Open Model
260
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
260
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Pharmacokinetic Models: Overview
761
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
761


